AstraZeneca’s Faslodex for breast cancer shows positive results in Phase III trial
Cambridge Network - News,
AstraZeneca has announced positive results from the Phase III FALCON trial comparing Faslodex 500mg (fulvestrant) to Arimidex…
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
Overview of attention for article published in Journal of Clinical Oncology, May 2016
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (94th percentile)
Mentioned by
- news
- 5 news outlets
- blogs
- 1 blog
- policy
- 2 policy sources
- 32 X users
- patent
- 19 patents
- 4 Facebook pages
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 534 Mendeley